MVCL-DTI:在异质图上使用多视图对比学习模型预测药物向相互作用
Bei Zhang1,2, Lijun Quan1,3, Zhijun Zhang1
1School of Computer Science and Technology, Soochow University, Jiangsu 215006, China.
Journal of chemical information and modeling
|January 15, 2025
概括
MVCL-DTI通过整合各种生物数据,准确地预测药物向相互作用 (DTI). 这种新的方法增强了药物发现和重新利用,显示了强大的概括性和实际适用性,特别是在COVID-19研究中.
科学领域:
- 计算生物学 计算生物学
- 生物信息学是一种生物信息学.
- 药物发现 药物发现 药物发现
背景情况:
- 准确预测药物向相互作用 (DTI) 对于加速药物发现和重新定位至关重要.
- 综合来自各种生物子网络的信息在DTI预测中构成了重大挑战.
研究的目的:
- 引入MVCL-DTI,这是一个基于图形的新型异质模型,用于预测DTI.
- 从多个生物数据视图有效地整合和适应权重信息.
主要方法:
- MVCL-DTI集成了邻居,元路径和扩散视图以捕获语义特征.
- 采用了基于注意力的对比学习方法和多视图注意力加权融合模块.
- 该模型的稳定性在各种条件下使用基准数据集进行了测试,包括硬负采样和掩盖已知的DTI.
主要成果:
- MVCL-DTI在各种测试场景中表现出强大的强大泛化.
- 该模型成功预测了新型DTI,具体适用于COVID-19相关药物.
- 功能可视化确定了关键元素,如基因本体学和影响DTI预测的替代节点.
结论:
- 通过利用异质图形信息,MVCL-DTI为DTI预测提供了一个有效的框架.
- 该模型的强大性能和实际适用性,特别是在抗病毒药物研究中,得到了强调.
- 了解特定特征和初始化策略的贡献,可以进一步优化DTI预测.
相关概念视频
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Agonism and Antagonism: Quantification
317
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
317
Drug-Receptor Interaction: Antagonist
2.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.7K


